Prof. Vincent Dousset
Pr. Vincent Dousset is professor in medical imaging at Bordeaux University and hospital practitioner at Bordeaux University Hospital. He leads the neuro-imaging department at Bordeaux University Hospital. He was the vice-president of International Relations at Bordeaux University. He is the head of the LabEx TRAIL. He is a member of the team of Prof. Stéphane Oliet "Glia-Neuron Interaction", at Inserm U862 laboratory.
Summary CV
Vincent Dousset, MD PhD, born in 1961, is director of the neuroradiology department at Bordeaux University Hospital since 2001, and vice-president of International Relations at Bordeaux University since 2008. He obtained his MD in 1991 and PhD in 1997. He worked as a research fellow at the University of Pennsylvania in 1990-1991 and became professor in medical imaging in 1999. Between 2007 and 2010 he was head of the Imaging “Pole” (coordinating all imaging departments) at Bordeaux University Hospital. Currently, he is member of the INSERM U862 laboratory on Neuronal Plasticity at the NeuroCentre Magendie (S. Oliet team). He is head of the TRAIL cluster of excellence: translational research and advanced imaging laboratory (http://trail.labex.u-bordeaux.fr/) TRAIL ANR-10-LabX 057, Investment for the Future grant (Budget: 9M€). He is also head of the Bordeaux Biomedical imaging platform, CNRS UMS 3428, at Bordeaux University. Vincent Dousset is Coordinator of the Bordeaux “node” of the “France Life Imaging” national infrastructure (budget 3.7 M€/37 M€). He obtained the 1st Lucien Appel Prize from the European Society of Neuroradiology and the Outstanding Teacher Award from the International Society of Magnetic Resonance in Medicine.
Selected References
1. Sibon I, Tourdias T, Felix S, Asselineau J, Bracoud L, Vivot A, Rouanet F, Renou P, Orgogozo JM, Dousset V. Magnetisation transfer parameters and stroke outcome. J Clin Neurosci. 2015 Jun;22(6):1012-7.
2. Crombé A, Saranathan M, Ruet A, Durieux M, de Roquefeuil E, Ouallet JC, Brochet B, Dousset V, Tourdias T. MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3T. AJNR Am J Neuroradiol. 2015 Mar;36(3):501-7.
3. Tourdias T, Roggerone S, Filippi M, Kanagaki M, Rovaris M, Miller DH, Petry KG, Brochet B, Pruvo JP, Radüe EW, Dousset V. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2012 Jul;264(1):225-33.
4. Tourdias T, Renou P, Sibon I, Asselineau J, Bracoud L, Dumoulin M, Rouanet F, Orgogozo JM, Dousset V. Final cerebral infarct volume is predictable by MR imaging at 1 week. AJNR Am J Neuroradiol. 2011 Feb;32(2):352-8.
5. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, Kim JS, Breuer L, Singer OC, Warach S, Christensen S, Treszl A, Forkert ND, Galinovic I, Rosenkranz M, Engelhorn T, Köhrmann M, Endres M, Kang DW, Dousset V, Sorensen AG, Liebeskind DS, Fiebach JB, Fiehler J, Gerloff C; STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 2011 Nov;10(11):978-86.